Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gutong Plaster for Moderate to Severe Cancer Pain
NCT07657390Phase 2Recruiting
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Dec 2025
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
A Phase 2 trial of Tianhe Gutong Tiegao in cancer pain, sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Started Dec 2025; status: recruiting.
02
Drugs
Tianhe Gutong Tiegao
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT07657390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07657390.